期刊
NANOMEDICINE
卷 2, 期 6, 页码 805-815出版社
FUTURE MEDICINE LTD
DOI: 10.2217/17435889.2.6.805
关键词
alpha particles; beta particles; dendrimers; liposomes; monoclonal; antibodies; nanotubes; radioimmunoimaging; radioimmunotherapy
资金
- NIGMS NIH HHS [T32 GM007739] Funding Source: Medline
Nanomaterials have garnered increasing interest recently as potential therapeutic drug-delivery vehicles. Among the existing nanomaterials are the pure carbon-based particles, such as fullerenes and nanotubes, various organic dendrimers, liposomes and other polymeric compounds. These vehicles have been decorated with a wide spectrum of target-reactive ligands, such as antibodies and peptides, which interact with cell-surface tumor antigens or vascular epitopes. Once targeted, these new nanomaterials can then deliver radioisotopes or isotope generators to the cancer cells. Here, we will review some of the more common nanomaterials under investigation and their current and future applications as drug-delivery scaffolds with particular emphasis on targeted cancer radiotherapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据